It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The global population is increasingly reliant on vaccines to maintain population health with billions of doses used annually in immunisation programmes. Substandard and falsified vaccines are becoming more prevalent, caused by both the degradation of authentic vaccines but also deliberately falsified vaccine products. These threaten public health, and the increase in vaccine falsification is now a major concern. There is currently no coordinated global infrastructure or screening methods to monitor vaccine supply chains. In this study, we developed and validated a matrix-assisted laser desorption/ionisation-mass spectrometry (MALDI-MS) workflow that used open-source machine learning and statistical analysis to distinguish authentic and falsified vaccines. We validated the method on two different MALDI-MS instruments used worldwide for clinical applications. Our results show that multivariate data modelling and diagnostic mass spectra can be used to distinguish authentic and falsified vaccines providing proof-of-concept that MALDI-MS can be used as a screening tool to monitor vaccine supply chains.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
















1 University of Oxford, Department of Chemistry, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
2 University of Oxford, Department of Biochemistry, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Kavli Institute for Nanoscience Discovery, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
3 Harwell Campus, Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UK Research and Innovation (UKRI), Didcot, UK (GRID:grid.76978.37) (ISNI:0000 0001 2296 6998)
4 Harwell Campus, Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UK Research and Innovation (UKRI), Didcot, UK (GRID:grid.76978.37) (ISNI:0000 0001 2296 6998); University of Twente, Hybrid Materials for Opto-Electronics Group, Department of Molecules and Materials, MESA+ Institute for Nanotechnology, Molecules Center and Center for Brain-Inspired Nano Systems, Faculty of Science and Technology, Enschede, the Netherlands (GRID:grid.6214.1) (ISNI:0000 0004 0399 8953)
5 University of Oxford, Medicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Mahidol University, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); University of Oxford, Infectious Diseases Data Observatory, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
6 Agilent Technologies LDA UK, Didcot, UK (GRID:grid.4991.5)
7 Mahidol University, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); University of Oxford, NDM Centre for Global Health Research, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Oxford University Hospitals NHS Foundation Trust, NIHR Oxford Biomedical Research Centre, Oxford, UK (GRID:grid.410556.3) (ISNI:0000 0001 0440 1440)
8 University of Huddersfield, Department of Pharmacy, School of Applied Sciences, Huddersfield, UK (GRID:grid.15751.37) (ISNI:0000 0001 0719 6059); University of East London, Water Lane, Department of Bioscience, School of Health, Sport and Bioscience, London, UK (GRID:grid.60969.30) (ISNI:0000 0001 2189 1306)
9 Harwell Campus, Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UK Research and Innovation (UKRI), Didcot, UK (GRID:grid.76978.37) (ISNI:0000 0001 2296 6998); University of Oxford, Medicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)